To provide the healthcare provider with a brief overview of the pathophysiology of osteoarthritis and rheumatoid arthritis and to discuss the various new and older treatment options currently available. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $45

To educate health care providers regarding newly released medications and to discuss the side effects, risks, benefits, and indications of each. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $45

*Supported by an educational grant from Novo Nordisk This presentation will provide information about the new 2025 diabetes guidelines updates published by the American Diabetes Association. Updates to diagnosis, monitoring, lifestyle, and long-term concerns will be outlined as well as highlights of new evidence. Emphasis will be placed on medication treatment for T2DM. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

Atrial fibrillation (AF) remains the most common arrhythmia in the general population and is associated with significant morbidity and mortality. Nurse Practitioners in all areas of practice will encounter these patients with various stages of AF and must be able to identify, classify and treat this common arrhythmia. Over the years the guidelines have changed, thus NPs must be aware of current treatment. This session will focus on the identification, treatment and prevention along with updated guidelines | 1.5 CE/CME category 1 credits (1.0 Pharmacology) | $35

This session will highlight recent advancements in infectious disease treatment. We will delve into new evidence from clinical trials and studies, focusing on emerging therapies, novel drug utilization, and the impact of these findings on clinical practice. Additionally, we will review key updates to major infectious disease guidelines, ensuring you have the most current information to optimize patient care and improve outcomes. | 1.5 CE/CME category 1 credits (1.5 Pharmacology) | $40

Clostridioides difficile infection (CDI) remains a significant healthcare burden, often arising as a consequence of antibiotic therapy. This presentation will delve into strategies aimed at minimizing CDI susceptibility, including judicious antibiotic use and the potential role of probiotics. We will then explore the current treatment guidelines for CDI, highlighting both commonalities and key differences across various recommendations. This comparative analysis will provide valuable insights for clinical decision-making. Finally, we will discuss emerging adjunctive therapies designed to reduce CDI recurrence. Evidence supporting the efficacy and safety of these new agents will be reviewed, along with practical clinical considerations for their appropriate use. | 1.5 CE/CME category 1 credits (1.5 Pharmacology) | $40

This program will discuss common and uncommon illness in the peds population and discuss treatment options. | 1.5 CE/CME category 1 credits (1.0 Pharmacology) | $35

To achieve success in your professional and personal life you must develop the art of communication. This is a skill set we can acquire through intentionality which can open doors we may never have imagined possible. Skilled communicators have better relationships, less conflict, and enhanced influence. This interactive session will focus on practical steps we can take to improve our communication skills | 1.5 CE/CME category 1 credits (0.0 Pharmacology) | $30

The off-label use of psychotropics to manage the neuropsychiatric symptoms associated with dementia is historically widespread. This is despite evidence showing limited benefits and high mortality risk. This interactive presentation is designed to explore a root cause analysis of these neuropsychiatric symptoms using an interdisciplinary approach. A review of recently approved antipsychotics for dementia related agitation will be discussed. | 1.5 CE/CME category 1 credits (1.0 Pharmacology) | $35